Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.

MLA

Yamai, Takuo, et al. “Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.” Cancers, vol. 15, no. 3, Feb. 2023. EBSCOhost, https://doi.org/10.3390/cancers15030970.

APA

Yamai, T., Ikezawa, K., Sugimoto, N., Urabe, M., Kai, Y., Takada, R., Nakabori, T., Uehara, H., Kawamura, T., Kunimasa, K., Yamamoto, S., Wakamatsu, T., Hayashi, T., Kukita, Y., Fujisawa, F., Inoue, T., Yamaguchi, Y., Yamasaki, T., Honma, K., & Ohkawa, K. (2023). Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers, 15(3). https://doi.org/10.3390/cancers15030970

Chicago

Yamai, Takuo, Kenji Ikezawa, Naotoshi Sugimoto, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, et al. 2023. “Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.” Cancers 15 (3). doi:10.3390/cancers15030970.